^○YUI OKUBO¹, Hitoshi MAESHIMA², Keiko OTSUKA¹ (1. Department of Pharmacy,Juntendo University Kosigaya Hospital, 2. Department of Psychiatry,Juntendo University Kosigaya Hospital)

^○Naoki FUKUI¹, Yutaro SUZUKI^{1, 3}, Takuro SUGAI¹, Junzo WATANABE⁴, Shin ONO^{5, 6}, Nobuto TSUNEYAMA¹, Misuzu TAJIRI², Toshiyuki SOMEYA² (1. Department of Psychiatry, Niigata University Medical and Dental Hospital, 2. Department of Psychiatry, Niigata University Graduate School of Medical and Dental Sciences, 3. Suehirobashi Hospital, 4. Shironemidorigaoka Hospital, 5. Niigata Psychiatric Center, 6. Department of Community Psychiatric Medicine, Niigata University Graduate School of Medical and Dental Sciences)

^○Takahiro NEMOTO¹, Takashi UCHINO¹, Sayaka AIKAWA¹, Satoshi MATSUO², Noriyuki MAMIYA², Yo WADA¹, Youji TAKUBO¹, Taiju YAMAGUCHI¹, Naoyuki KATAGIRI¹, Naohisa TSUJINO¹, Yoshiyuki SHIBASAKI², Tomohiro USAMI², Masafumi MIZUNO¹ (1. Department of Neuropsychiatry, Toho University School of Medicine, 2. Department of Medical Affairs, Otsuka Pharmaceutical Co., Ltd.)

^○Keisuke KUSUDO¹, Ryo OCHI², Shinichiro NAKAJIMA¹, Hiroyuki UCHIDA¹, Takefumi SUZUKI³, Fernando CARAVAGGIO⁴, Tarek K RAJJI⁴, Wanna MAR⁴, Philip GERRETSEN⁴, Benoit H MULSANT⁴, Bruce G POLLOCK⁴, Masaru MIMURA¹, David C MAMO⁵, Ariel GRAFF-GUERRERO⁴ (1. Keio University school of Medicine, Depertment of Neuropsychiatry, Tokyo, Japan., 2. Keio University, Faculty of Environment and Information, Yokohama, Japan., 3. University of Yamanashi, Department of Neuropsychiatry and Clinical Ethics, Kofu, Japan., 4. University of Toronto, Department of Psychiatry, Toronto, Canada., 5. University of Malta, Department of Psychiatry, Msida, Malta.)